See more : Nutroganics, Inc. (NUTTQ) Income Statement Analysis – Financial Results
Complete financial analysis of C21 Investments Inc. (CXXIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of C21 Investments Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Bank Linth LLB AG (LINN.SW) Income Statement Analysis – Financial Results
- Regis Resources Limited (RGRNF) Income Statement Analysis – Financial Results
- Telcoware Co.,Ltd. (078000.KS) Income Statement Analysis – Financial Results
- Cantabio Pharmaceuticals, Inc. (CTBO) Income Statement Analysis – Financial Results
- Northern Data AG (NDTAF) Income Statement Analysis – Financial Results
C21 Investments Inc. (CXXIF)
About C21 Investments Inc.
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. It offers packaged and wholesale flower, vaporizer pens, cured extracts, edibles, pre-rolls, tinctures, and topicals; and payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.67M | 28.89M | 32.98M | 36.13M | 37.71M | 2.59M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 132.34K | 142.80K | 139.45K | 249.20K | 109.46K | 34.29K | 28.48K | 8.96K | 26.97K | 2.33K | 8.04K | 5.50K | 35.21K | 86.45K |
| Cost of Revenue | 18.62M | 15.49M | 14.17M | 17.48M | 24.38M | 2.40M | 0.00 | 0.00 | 0.00 | 0.00 | 119.64K | 0.00 | 44.80K | 40.37K | 72.07K | 141.71K | 0.00 | 10.97K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 8.05M | 13.40M | 18.81M | 18.65M | 13.32M | 182.57K | 0.00 | 0.00 | 0.00 | 0.00 | -119.64K | 0.00 | 87.55K | 102.43K | 67.38K | 107.49K | 109.46K | 23.32K | 28.48K | 8.96K | 26.97K | 2.33K | 8.04K | 5.50K | 35.21K | 86.45K |
| Gross Profit Ratio | 30.19% | 46.39% | 57.03% | 51.63% | 35.33% | 7.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 66.15% | 71.73% | 48.32% | 43.13% | 100.00% | 68.02% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.59M | 8.00M | 7.77M | 7.46M | 10.01M | 8.84M | 627.06K | 52.36K | 71.44K | 73.50K | 238.64K | 171.06K | 143.40K | 362.43K | 160.25K | 270.75K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 75.56K | 83.67K | 399.37K | 166.48K | 1.12M | 2.31M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.61K | 3.69K | 12.93K | 5.30K | 4.42K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.66M | 8.08M | 7.77M | 7.63M | 11.13M | 11.15M | 627.06K | 52.36K | 71.44K | 73.50K | 238.64K | 171.06K | 147.09K | 375.35K | 165.55K | 275.16K | 158.50K | 258.84K | 171.20K | 180.81K | 170.57K | 107.84K | 124.52K | 149.05K | 209.54K | 227.13K |
| Other Expenses | 0.00 | 1.37M | 1.28M | 2.11M | 3.41M | -673.23K | 0.00 | 0.00 | 0.00 | 0.00 | 119.36K | -3.61K | 0.00 | 0.00 | 0.00 | 190.50K | 59.77K | 143.69K | 18.23K | 11.29K | -0.75 | 2.19K | 2.14K | -37.54K | -5.21K | 13.17K |
| Operating Expenses | 9.68M | 9.45M | 9.06M | 9.74M | 14.54M | 11.72M | 627.06K | 52.36K | 71.44K | 73.50K | 358.01K | 171.06K | 147.09K | 375.35K | 165.55K | 465.66K | 185.69K | 280.78K | 189.42K | 192.11K | 185.16K | 110.03K | 126.66K | 152.59K | 222.33K | 334.09K |
| Cost & Expenses | 26.81M | 24.93M | 23.23M | 27.22M | 38.92M | 14.13M | 627.06K | 52.36K | 71.44K | 73.50K | 358.01K | 171.06K | 191.89K | 415.72K | 237.62K | 607.37K | 185.69K | 291.75K | 189.42K | 192.11K | 185.16K | 110.03K | 126.66K | 152.59K | 222.33K | 334.09K |
| Interest Income | 0.00 | 456.69K | 1.31M | 5.15M | 2.35K | 337.99K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.85 | 158.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 35.21K | 456.69K | 1.31M | 4.49M | 4.30M | 1.38M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 882.83 | 1.60K | 1.82K | 3.38K | 4.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.33M | 2.32M | 2.27M | 1.39M | 4.99M | 618.42K | 599.47K | 1.06K | 978.80 | 3.43K | 7.18K | 595.23K | 43.44K | 727.97K | 486.31K | 190.50K | 27.19K | 21.94K | 18.23K | 11.29K | 14.59K | 2.19K | 2.14K | 3.54K | 12.80K | 106.96K |
| EBITDA | 3.86M | 6.26M | 20.45M | 5.07M | -19.60M | -21.43M | -31.10K | -52.63K | -67.49K | -77.25K | -365.48K | -143.54K | -59.54K | -272.92K | -98.15K | -1.12M | -49.03K | -235.52K | 953.56K | -198.38K | -143.60K | 405.62K | -116.48K | -143.55K | -174.33K | 228.05K |
| EBITDA Ratio | 14.47% | 21.67% | 35.42% | 34.78% | 10.63% | -425.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -44.99% | -191.12% | -70.39% | -67.22% | -42.73% | -616.83% | 3,348.53% | -2,212.89% | -532.46% | 17,385.96% | -1,448.88% | -1,816.38% | -495.15% | 263.79% |
| Operating Income | 1.47M | 3.96M | 9.75M | 7.52M | -971.81K | -12.03M | -627.06K | -52.36K | -71.44K | -73.50K | -358.01K | -171.06K | -102.99K | -1.00M | -584.47K | -1.32M | -78.48K | -281.50K | -1.26M | -156.62K | -158.19K | -618.82K | -118.62K | -190.71K | -187.13K | -616.37K |
| Operating Income Ratio | 5.52% | 13.69% | 29.58% | 20.82% | -2.58% | -465.16% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -77.82% | -700.89% | -419.13% | -530.36% | -71.70% | -821.05% | -4,414.89% | -1,747.07% | -586.57% | -26,524.20% | -1,475.52% | -3,466.65% | -531.51% | -712.96% |
| Total Other Income/Expenses | -1.21M | 236.07K | 7.38M | -10.95M | -27.66M | -11.57M | 0.00 | 268.25 | 3.94K | -3.74K | -7.47K | -598.89K | -43.47K | -381.61K | -504.77K | -965.22K | 86.31K | 118.94K | 1.26M | 29.22K | -1.51 | 618.82K | 0.00 | -81.16K | -5.21K | -355.56K |
| Income Before Tax | 258.66K | 4.19M | 17.13M | -3.74M | -28.84M | -23.60M | -627.06K | -52.36K | -67.95K | -76.94K | -365.19K | -767.17K | -104.59K | -1.00M | -603.18K | -1.32M | 7.82K | -138.35K | -2.35M | -127.40K | -158.19K | -1.13M | 0.00 | -271.87K | -192.33K | -971.93K |
| Income Before Tax Ratio | 0.97% | 14.51% | 51.94% | -10.35% | -76.49% | -912.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -79.03% | -702.16% | -432.54% | -530.30% | 7.15% | -403.52% | -8,264.60% | -1,421.15% | -586.58% | -48,432.31% | 0.00% | -4,941.88% | -546.29% | -1,124.25% |
| Income Tax Expense | 3.48M | 2.81M | 3.97M | 2.37M | 3.71M | -10.19M | -599.47K | -1.06K | 0.00 | 0.00 | 0.00 | -35.77K | -41.84K | -726.15K | -482.93K | -5.27K | -24.28K | -352.89K | 1.10M | -11.44K | 13.75K | 522.46K | 14.30K | 54.83K | 18.54K | 402.07K |
| Net Income | -3.31M | 1.38M | 9.95M | -6.11M | -32.56M | -23.60M | -627.06K | -52.36K | -67.95K | -76.94K | -365.19K | -730.52K | -104.59K | -1.00M | -603.18K | -1.32M | 7.82K | 214.54K | -1.26M | -169.01K | -171.95K | -630.16K | -132.92K | -239.46K | -210.87K | -636.54K |
| Net Income Ratio | -12.39% | 4.78% | 30.18% | -16.90% | -86.34% | -912.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -79.03% | -702.16% | -432.54% | -528.19% | 7.15% | 625.75% | -4,419.08% | -1,885.30% | -637.57% | -27,010.06% | -1,653.38% | -4,352.68% | -598.94% | -736.29% |
| EPS | -0.03 | 0.01 | 0.08 | -0.06 | -0.42 | -0.76 | -0.13 | -0.03 | -0.04 | -0.04 | -0.20 | -0.63 | -0.11 | -1.18 | -0.90 | -2.13 | 0.01 | 0.41 | -2.79 | -0.42 | -0.47 | -1.82 | -0.41 | -0.76 | -0.75 | -2.80 |
| EPS Diluted | -0.03 | 0.01 | 0.08 | -0.06 | -0.42 | -0.76 | -0.13 | -0.03 | -0.04 | -0.04 | -0.20 | -0.63 | -0.11 | -1.18 | -0.90 | -2.13 | 0.01 | 0.41 | -2.79 | -0.42 | -0.47 | -1.82 | -0.41 | -0.76 | -0.75 | -2.80 |
| Weighted Avg Shares Out | 120.05M | 120.05M | 118.31M | 104.84M | 76.68M | 31.00M | 5.00M | 1.98M | 1.87M | 1.85M | 1.85M | 1.16M | 994.70K | 849.13K | 672.00K | 617.99K | 607.30K | 521.44K | 450.57K | 405.69K | 369.14K | 346.94K | 321.54K | 317.15K | 281.65K | 227.65K |
| Weighted Avg Shares Out (Dil) | 120.05M | 122.88M | 121.14M | 104.84M | 76.68M | 31.00M | 5.00M | 1.98M | 1.87M | 1.85M | 1.85M | 1.16M | 994.70K | 849.13K | 672.00K | 617.99K | 607.30K | 521.44K | 450.57K | 405.69K | 369.14K | 346.94K | 321.54K | 317.15K | 281.65K | 227.65K |
C21 Investments Announces Q2 Earnings Date and Provides Operational Update
New Dispensary Generating Strong Sales Growth during the Quarter Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced its expected date for reporting...
C21 Investments Provides MCTO Status Update
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, is providing a default status report in accordance with the alternative information guidelines set out...
C21 Investments Provides MCTO Status Update
Vancouver, British Columbia--(Newsfile Corp. - July 12, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, is providing a default status report in accordance with the alternative information guidelines set out...
Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management
C21 Investments CXXI and Vext Science VEXT have demonstrated notable financial performance, particularly in cash flow and credit stability. This is significant given the challenges faced by many larger cannabis companies.
C21 Investments Provides MCTO Status Update
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, is providing a default status report in accordance with the alternative information guidelines set out...
C21 Investments Announces Change to Financial Year-End, Delay in Filing Annual Financial Results and Application for Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - May 31, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced that the Company will change its financial year end from January 31 to...
C21 Announces Closing of C$4 Million Private Placement of Convertible Debenture Units
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company") is pleased to announce the closing of its non-brokered private placement offering of convertible debenture units of the Company (collectively,...
Reasons To Be Cautiously Optimistic About Cannabis
Cautious optimism is warranted in the cannabis industry due to potential changes, such as the move to federal legalization and improved fundamentals. Investors should consider their risk appetite, timeframes, and political catalysts when choosing cannabis companies to invest in.
C21 Investments Reports Slightly Lower Q3 Revenue, 10th Straight Quarter Of Positive Free Cash Flow
Vertically integrated cannabis company C21 Investments Inc. (CSE:CXXI) (OTCQX:CXXIF) announced its unaudited results on Thursday for the third quarter ended October 31, 2021. "C21 continues to deliver positive free cash flow and profitable bottom-line performance," Sonny Newman, the company's president and CEO said.
C21 Announces Release Date of Fiscal Year End Financial Results
Provides Cultivation Expansion Update and Sees Record Retail Revenue for March at its Nevada DispensariesVancouver, British Columbia--(Newsfile Corp. - April 15, 2021) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically-integrated cannabis company today announces it...
Source: https://incomestatements.info
Category: Stock Reports